Lisa Krebes
Wuerzburg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
C-type natriuretic peptide attenuates enhanced glycolysis and de novo pyrimidine synthesis in pericytes of patients with pulmonary arterial hypertension.
Journal: Communications biology
Published: December 16, 2024
Auto/Paracrine C-Type Natriuretic Peptide/Cyclic GMP Signaling Prevents Endothelial Dysfunction.
Journal: International journal of molecular sciences
Published: May 20, 2024
C-type natriuretic peptide/cGMP/FoxO3 signaling attenuates hyperproliferation of pericytes from patients with pulmonary arterial hypertension.
Journal: Communications biology
Published: July 27, 2023
Heart-Microcirculation Connection: Effects of ANP (Atrial Natriuretic Peptide) on Pericytes Participate in the Acute and Chronic Regulation of Arterial Blood Pressure.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: September 21, 2020
Natriuretic Peptides Attenuate Retinal Pathological Neovascularization Via Cyclic Guanosine Monophosphate Signaling in Pericytes and Astrocytes.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: October 18, 2019
β Cell-specific deletion of guanylyl cyclase A, the receptor for atrial natriuretic peptide, accelerates obesity-induced glucose intolerance in mice.
Journal: Cardiovascular diabetology
Published: March 06, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026